Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McClellan Resigns As Head Of CMS, Claiming Drug Benefit Is On A Stable Track

This article was originally published in The Pink Sheet Daily

Executive Summary

McClellan notes accomplishments in implementing Medicare Part D as he ends two-and-a-half years as Medicare and Medicaid chief.

You may also be interested in...



Randall Lutter Appointed FDA Acting Deputy For Policy

Lutter will step in when Scott Gottlieb leaves the post Jan. 16.

Randall Lutter Appointed FDA Acting Deputy For Policy

Lutter will step in when Scott Gottlieb leaves the post Jan. 16.

Deputy Commissioner Scott Gottlieb To Leave FDA Jan. 16

Gottlieb will return to the American Enterprise Institute to work on health policy issues with former FDA/CMS chief Mark McClellan.

Topics

UsernamePublicRestriction

Register

PS051363

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel